Lucid Diagnostics Inc. announced that skilled healthcare executive John R. Palumbo has been appointed to the board of directors, effective September 22, 2025. Palumbo is a senior medical executive with a four-year career spanning early stage ventures, growth companies and Fortune 100 companies. He launched two companies through IPOs, scaled up startups and led major transformation initiatives in large, complex organizations.
Most recently, he served as executive chairman of ValueHealth, a value-based surgical platform, and led the company through recapitalization and strategic investments in 2018. Previously, he took on the senior executive role at Amerisourcebergen Corporation (now Cencora Inc.), leading the provider business unit and its consulting and technical division. During his tenure, the group expanded to a multi-billion dollar platform serving health systems across the country.
Previously, Palumbo was Chief Operating Officer of Allscripts Healthcare Solutions Inc., where he oversaw the transformation into one of the company's first electronic medical record platforms. Prior to that, he served as president of I-Trax Inc. (now part of Premise Health), building it into a national leader in on-site primary care, pharmacy and population health services for Fortune 500 employers. He began his career in the Shared Health System (SMS), where he led National Health Services and Outsourcing Services. For the past 15 years, Palumbo has served as chairman, director and senior advisor for healthcare technology, services and medical device companies supported by institutional and strategic investors.
He currently serves on the committees of PM Pediatrics, IVWatch and Qless, and serves as a chair on the advisory board of Brado, an AI-led engagement platform that serves Health Systems.
